LNDriver: identifying driver genes by integrating mutation and expression data based on gene-gene interaction network
暂无分享,去创建一个
Junfeng Xia | Chun-Hou Zheng | Di Zhang | Pi-Jing Wei | C. Zheng | Pi-Jing Wei | Di Zhang | Junfeng Xia
[1] Yuan Ren,et al. SHP2E76K mutant promotes lung tumorigenesis in transgenic mice. , 2014, Carcinogenesis.
[2] Giovanni Tesoriere,et al. RB1 in cancer: Different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis , 2013, Journal of cellular physiology.
[3] K. Rauen,et al. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. , 2009, Current opinion in genetics & development.
[4] Steven J. M. Jones,et al. Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.
[5] D. Goodrich,et al. RB1, development, and cancer. , 2011, Current topics in developmental biology.
[6] R. Gibbs,et al. Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 , 2011, Science.
[7] Yoh Iwasa,et al. An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer , 2015, PLoS Comput. Biol..
[8] Steven J. M. Jones,et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.
[9] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[10] Sandhya Rani,et al. Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..
[11] Michael B. Stadler,et al. Tyrosine phosphatase SHP2 increases cell motility in triple-negative breast cancer through the activation of SRC-family kinases , 2014, Oncogene.
[12] Makoto Nishio,et al. Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer , 2014, Cancer medicine.
[13] Kyusam Choi,et al. The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas , 2012, Modern Pathology.
[14] J. P. Hou,et al. DawnRank: discovering personalized driver genes in cancer , 2014, Genome Medicine.
[15] Simon C. K. Shiu,et al. Molecular Pattern Discovery Based on Penalized Matrix Decomposition , 2011, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[16] A. Gonzalez-Perez,et al. Functional impact bias reveals cancer drivers , 2012, Nucleic acids research.
[17] Gary D Bader,et al. International network of cancer genome projects , 2010, Nature.
[18] Matthew B. Callaway,et al. MuSiC: Identifying mutational significance in cancer genomes , 2012, Genome research.
[19] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[20] Zhongming Zhao,et al. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes , 2016, Briefings Bioinform..
[21] S. Nelson,et al. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation , 2010, Nature.
[22] Shi-Hua Zhang,et al. Efficient methods for identifying mutated driver pathways in cancer , 2012, Bioinform..
[23] P. Ladenson,et al. BRAF mutation in papillary thyroid carcinoma. , 2003, Journal of the National Cancer Institute.
[24] Desmond J. Higham,et al. GeneRank: Using search engine technology for the analysis of microarray experiments , 2005, BMC Bioinformatics.
[25] Khee Chee Soo,et al. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma , 2008, Genes, chromosomes & cancer.
[26] Peilin Jia,et al. VarWalker: Personalized Mutation Network Analysis of Putative Cancer Genes from Next-Generation Sequencing Data , 2014, PLoS Comput. Biol..
[27] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[28] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[29] A. Sivachenko,et al. Sequence analysis of mutations and translocations across breast cancer subtypes , 2012, Nature.
[30] A. Bashashati,et al. DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer , 2012, Genome Biology.
[31] Q. Gao,et al. Expression and clinical significance of tyrosine phosphatase SHP2 in thyroid carcinoma. , 2015, Oncology letters.
[32] Brad T. Sherman,et al. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.
[33] A. D. Dei Tos,et al. Soft tissue tumors associated with EWSR1 translocation , 2010, Virchows Archiv.
[34] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[35] Brian H. Dunford-Shore,et al. Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.
[36] Setia Pramana,et al. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival , 2015, Bioinform..
[37] Simon C. K. Shiu,et al. Metasample-Based Sparse Representation for Tumor Classification , 2011, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[38] Shi-Hua Zhang,et al. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data , 2013, BMC Systems Biology.
[39] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[40] M. Frame,et al. Src in cancer: deregulation and consequences for cell behaviour. , 2002, Biochimica et biophysica acta.